• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pharmacokinetic study of slow-release preparation of sodium valproate (KW-6066N): multiple dose administration test and the steady-state serum level profiles in epileptic patients.

作者信息

Takeda A, Hishida H, Amioka K, Sakamoto Y, Terao S, Ishikawa S, Aoki H

机构信息

Department of Internal Medicine, Nagoya National Hospital.

出版信息

Jpn J Psychiatry Neurol. 1989 Sep;43(3):515-6. doi: 10.1111/j.1440-1819.1989.tb02963.x.

DOI:10.1111/j.1440-1819.1989.tb02963.x
PMID:2516565
Abstract
摘要

相似文献

1
Pharmacokinetic study of slow-release preparation of sodium valproate (KW-6066N): multiple dose administration test and the steady-state serum level profiles in epileptic patients.丙戊酸钠缓释制剂（KW-6066N）的药代动力学研究：癫痫患者的多剂量给药试验及稳态血清水平曲线
Jpn J Psychiatry Neurol. 1989 Sep;43(3):515-6. doi: 10.1111/j.1440-1819.1989.tb02963.x.
2
[Serum valproic acid concentrations in monotherapy with 1, 2 and multiple administrations per day].[每日1次、2次及多次给药单药治疗时的血清丙戊酸浓度]
Nervenarzt. 1986 Nov;57(11):640-8.
3
Effectiveness and plasma levels of sodium valproate monotherapy in the treatment of epilepsies in children: a further study.丙戊酸钠单药治疗儿童癫痫的有效性及血药浓度：进一步研究
Jpn J Psychiatry Neurol. 1989 Sep;43(3):517-8. doi: 10.1111/j.1440-1819.1989.tb02964.x.
4
Pharmacokinetics of slow-release preparations of sodium valproate.丙戊酸钠缓释制剂的药代动力学
Psychiatry Clin Neurosci. 1995 Dec;49(5-6):309-10. doi: 10.1111/j.1440-1819.1995.tb01910.x.
5
A trial of once-daily administration of KW6066N for patients with benign rolandic and primary generalized epilepsy.一项针对良性罗兰多型癫痫和原发性全身性癫痫患者每日一次服用KW6066N的试验。
Jpn J Psychiatry Neurol. 1988 Sep;42(3):580-2. doi: 10.1111/j.1440-1819.1988.tb01365.x.
6
Quantitative EEG effects and plasma concentration of sodium valproate: acute and long-term administration to epileptic patients.丙戊酸钠的定量脑电图效应及血浆浓度：对癫痫患者的急性和长期给药
Neuropsychobiology. 1989;22(4):231-5. doi: 10.1159/000118622.
7
High-dose sodium valproate therapy for childhood refractory epilepsy.高剂量丙戊酸钠治疗儿童难治性癫痫
Jpn J Psychiatry Neurol. 1990 Jun;44(2):343-4.
8
[The pharmacokinetic optimization of depakin in children with epilepsy].[德巴金在癫痫患儿中的药代动力学优化]
Zh Nevrol Psikhiatr Im S S Korsakova. 1994;94(6):37-8.
9
Interaction between valproate formulation and phenytoin concentrations.
Eur J Clin Pharmacol. 1995;48(1):61-3. doi: 10.1007/BF00202174.
10
Valproic acid pharmacokinetics in children: III. Very high dosage requirements.
Pediatr Neurol. 1986 Jul-Aug;2(4):202-8. doi: 10.1016/0887-8994(86)90047-0.

引用本文的文献

1
Interaction between valproate formulation and phenytoin concentrations.
Eur J Clin Pharmacol. 1995;48(1):61-3. doi: 10.1007/BF00202174.
2
Pharmacokinetic evaluation of sustained release formulations of antiepileptic drugs. Clinical implications.
Clin Pharmacokinet. 1992 Jan;22(1):11-21. doi: 10.2165/00003088-199222010-00002.